🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single-arm, open-label study that will examine the effect of abro...
Status
Completed
Location
Inno-6050 Site 22
Start Date
2022-11-25
Trial ID
NCT05602207
Treatments Being Tested
The purpose of this study is to learn about the safety and effectiveness (h...
Status
Active Not Recruiting
Location
Pfizer Local Country Office
Start Date
2022-04-19
Trial ID
NCT05387980
Treatments Being Tested
The purpose of this observational study is to learn about the safety of abr...
Status
Recruiting
Location
Pfizer
Start Date
2023-07-25
Trial ID
NCT05721937
Treatments Being Tested
The purpose of this non-interventional study is to learn about the safety a...
Status
Recruiting
Location
Pfizer Tower
Start Date
2023-01-07
Trial ID
NCT05391061
Treatments Being Tested
This study aims to evaluate the safety, efficacy and tolerability of abroci...
Status
Completed
Location
INNO-6052 Site 12
Start Date
2024-05-31
Trial ID
NCT06283550
Treatments Being Tested
The primary objective is to determine if JAK1 specific inhibition is effect...
Status
Active Not Recruiting
Location
Yale University
Start Date
2023-10-27
Trial ID
NCT05650736
Treatments Being Tested
This is a prospective, multi-center observational study characterizing clin...
Status
Recruiting
Location
Allergy and Asthma Medical Group and Research Center
Start Date
2026-04-24
Trial ID
NCT06899204
Treatments Being Tested
The purpose of this study is to investigate the role of the oral JAK1 inhib...
Status
Completed
Location
Yale University
Start Date
2023-06-01
Trial ID
NCT05696795
Treatments Being Tested
A multi-center, placebo-controlled, double blind, 1:1:1 randomized control ...
Status
Active Not Recruiting
Location
Children's Hospital Orange County
Start Date
2023-10-19
Trial ID
NCT05743244
Treatments Being Tested